SynthesisSurgical endoscopy2017
Comparison of laparoscopic liver resection for lesions located in anterolateral and posterosuperior segments: a meta-analysis.
Synthesis in Surgical endoscopy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03270917 (The ORANGE SEGMENTS - Trial), which is not on this map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The ORANGE SEGMENTS - Trial: an International Multicentre Randomized Controlled Trial of Open Versus Laparoscopic Parenchymal Preserving Postero-superior Liver Segment Resection
Who cites it
11 citing papers in PubMed.
- Better outcomes of robotic liver resection in segment VII/VIII compared to open and laparoscopic approach.Journal of robotic surgery · 2026Article
- Adoption of pure laparoscopic liver resections: a single-institution experience with the first 1000 consecutive resections.Surgical endoscopy · 2026Article
- The differential benefit of laparoscopic over open minor liver resection for lesions situated in the anterolateral or posterosuperior segments.Hepatobiliary surgery and nutrition · 2024Article
- Perioperative and long-term survival outcomes of laparoscopic versus open hepatectomy for BCLC stage A large hepatocellular carcinoma patients in difficult segments: A two-centre, propensity score matching analysis.Frontiers in oncology · 2023Article
- Indications for open hepatectomy in the era of laparoscopic liver resection: a high volume single institutional study.Journal of liver cancer · 2022Article
- Robot-assisted liver resection: the real benefit so far.Langenbeck's archives of surgery · 2022Review
- Article
- All the Routes for Laparoscopic Liver Segment VIII Resection: A Comprehensive Review of Surgical Techniques.Frontiers in oncology · 2022Review
- Minimally invasive resection of posterosuperior liver tumors in the supine position using intra-abdominal trocars.Surgical endoscopy · 2020Article
- Laparoscopic liver resection: a review of current indications and surgical techniques.Hepatobiliary surgery and nutrition · 2018Review
- Recent advances in the surgical management of hepatocellular carcinoma.Annals of gastroenterologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLaparoscopic liver resection (LLR) is mostly performed to treat benign lesions at easily accessible locations. With improvements in instruments and accumulation of experience, LLR has evolved to treat malignant tumors with major hepatectomy, even in less accessible locations, without compromising the principles of safety and oncology. The present meta-analysis aimed to compare the outcomes of LLR for lesions located in anterolateral (AL) (II, III, IVb, V, and VI) and posterosuperior (PS) (I, IVa, VII, and VIII) liver segments.
methodsA comprehensive search was conducted to identify all eligible studies. This meta-analysis was performed using the STATA 12.0 statistical software. Standardized mean differences (SMDs) and odds ratios (ORs) were calculated for continuous variables and dichotomous variables, respectively, with 95% confidence intervals (CIs).
resultsA total of 846 patients from five studies were identified for the final analysis, with 565 patients in the AL group and 281 in the PS group. Although the operation time (SMD -0.60; 95% CI -0.75 to -0.45; P = 0.000) and conversion rate (OR 0.40; 95% CI 0.24-0.67; P = 0.000) were lower and the resection margin was wider (SMD 0.2; 95% CI 0.03-0.37; P = 0.019) in the AL group than in the PS group, no significant differences in blood loss (SMD -0.29; 95% CI -0.68 to 0.09; P = 0.131), complication rate (OR 0.73; 95% CI 0.50-1.07; P = 0.103), hospital stay (SMD -0.53; 95% CI -1.16 to 0.11; P = 0.105), and tumor recurrence (OR 1.23; 95% CI 0.81-1.86; P = 0.334) were noted between the groups.
conclusionLLR is technically feasible and safe for selected patients with lesions in the PS segments of the liver.
Indexed as
Identifiers
28389796What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.